Skeletal muscle loss, serum AFP, and CRP levels have been identified as potential predictors of overall survival and tumor response in unresectable HCC patients undergoing the combination of TKIs and PD-1 inhibitors (42). This evidence concerns the gene CRP and neoplasm.